Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker boosts IGA (international government affairs) with high-profile appointment

This article was originally published in Clinica

Executive Summary

Orthopaedics industry market leader Stryker has appointed international medical device industry and government affairs specialist Ed Rozynski to head its newly-created international government affairs (IGA) function. The appointment of Mr Rozynski as vice-president of international government affairs appears to be part of a concerted effort by the Kalamazoo, Michigan company to raise its profile on public policy and reimbursement issues. Stryker International president Luciano Cattani said: "Ed brings a wealth of experience and expertise and visibility to this role. His worldwide perspective and advice is sought out by foreign healthcare leaders." Mr Rozynski was most recently vice-president of international government affairs at St Jude Medical (focusing on developing strategy and international market access), prior to which he served as an international consultant to the industry, helping to secure favourable reimbursement and policy outcomes in Japan, Europe and the Americas. His healthcare industry responsibilities have also included 12 years with AdvaMed. At Stryker, he will also act as adviser to CEO Steve MacMillan, who has just assumed the chairmanship of AdvaMed's international committee.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel